Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
NBIX.OQ - Neurocrine Biosciences Inc
Neurocrine Biosciences Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 04:50PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome once again to TD Cowan's forty-sixth annual Healthcare Conference. I'm Phil Nado, one of the biotech analysts here at Cowan, and it's my pleasure to moderate a fireside chat with Neurocrine Biosciences. Those of you who follow our research know that Neurocrine is one of our top picks for this year based on its growth prospects. So we're happy to push the team on that today. We have with us Kyle Gaino, CEO, Jude Ona, the, CSO, and Todd Tusla, Vice President of IR. Guys, I'll kick it to you to start. Can you give us a brief state of the company overview, biggest strengths, biggest challenges, and what does Nurocrine need to achieve to drive up performance over the next year or two?
Trustpilot
